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A B S T R A C T
In recent years, there has been a growing interest to explore the responsiveness to injury in steatotic
hepatocyte. VL-17A cells, which express ADH and Cyp2E1 overloaded with free fatty acids (1 mM of oleic
and palmitic acid 2:1) showed an increased oxidative damaged after 24 h free fatty acids treatment when
exposed to ethanol (100 mM) for 48 h as a second injury. An increment in reactive oxygen species, de-
termined by DCFH-DA, protein oxidation, and apoptosis were observed although an increase in main
antioxidant proteins such as superoxide dismutase 1 and glutathione peroxidase were observed, but failed
in gamma-glutamylcysteine synthetase, suggesting a decreased capacity of synthesis of glutathione com-
pared with cells treated only with free fatty acids or ethanol. The increased oxidative stress and toxicity
in lipid overloaded VL-17A cells subjected to ethanol exposure were accompanied by increases in Cyp2E1
protein expression. Our data show that lipid loaded in an in vitro model, VL-17A cells, is more suscep-
tible to cell damage and oxidative stress when treated with ethanol.
© 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Non-alcoholic fatty liver disease (NAFLD), a spectrum of liver
damage ranging from steatosis to stetohepatitis and cirrhosis, is the
most common liver disease in clinical practice (Duvnjak et al., 2009).
Themechanisms by which steatosis leads to hepatocyte damage and
inflammation observed in non-alcoholic steatohepatitis (NASH) is
not well understood although it has been correlated with in-
creased inflammatory cytokine levels, elevated cytochrome P450
(Cyp) activity, specifically the isoforms 2E1 and 4A, impairing mi-
tochondrial function, reducing ATP levels, and promoting oxidative
damage (Daly, 2013; Enriquez-Cortina et al., 2013; Gutierrez Ruiz
et al., 2012; Robertson et al., 2001). Based on this evidence, some
authors consider that steatosis renders hepatocytes susceptible to
damage to another aggression (Robertson et al., 2001). It has been
generally proposed that the aggression increases the production of
reactive oxygen species (ROS) in the steatotic hepatocyte result-
ing in the progression of cellular damage (Sumida et al., 2013) So,
fatty liver may predispose the organ to further injury (hepatitis and
fibrosis) by Cyp2E1 activity induction, free radicals generation, lipid
peroxidation, nuclear factor-kappa B (NF-κB) activation, and in-
creased transcription of proinflammatorymediators, including tumor
necrosis factor-alpha (TNF-α) (Begriche et al., 2013; Robertson et al.,
2001). Liver steatosis induces sensitization to damage under isch-
emia, endotoxin, and alcohol (Soltys et al., 2001). Steatotic livers are
particularly vulnerable to ischemia/reperfusion injury, resulting in
an increased risk of postoperative morbidity andmortality after liver
surgery, including liver transplantation (Tashiro et al., 2014). Fatty
overload in the organ has been related to liver transplant failure that
could be linked to oxidative stress (Reiniers et al., 2014), and el-
evated free fatty acid (FFA) levels, especially saturated, such as
palmitic acid, may be predisposing factors for cyclosporine A tox-
icity (Luo et al., 2012), and patients with underlying diseases that
would elevate free fatty acids may be susceptible to toxicity that
worsens the outcome in transplant patients (Luo et al., 2012). Ste-
atosis negatively influences the rate of response to antiviral hepatitis
C treatment, as confirmed by large clinical trials (Negro, 2006).
Obesity dramatically increases the risk of having advanced fibro-
sis in all chronic liver diseases (Rosselli et al., 2014), on par with
the well-described risk of alcohol ingestion (Riley et al., 2009). On
the other hand, obesity may contribute to the development of al-
coholic liver disease by generating free radicals, increasing TNF-α
production, inducing insulin resistance, and producing fibrogenic
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agents, such as angiotensin II, norepinephrine, neuropeptide Y, and
leptin (Purohit et al., 2004). The wide prevalence of alcohol abuse
in society makes it an important cofactor in many other liver dis-
eases, including chronic viral hepatitis, disorders of iron overload,
and obesity-related liver disease (Zakhari, 2013).
In vitro models of steatosis have been used to study the hepa-
tocellular consequences of lipid accumulation in hepatic cells
(Gómez-Lechón et al., 2007; Tu et al., 2014; Yang et al., 2010). These
models are hepatocyte cell lines and primary hepatocytes treated
in culture with monounsaturated and saturated fatty acids, which
seem to reproduce the key features of NAFLD in humans. Conse-
quently, well-standardized and relevant in vitro hepatic cellular
models have been very useful to help experimentally investigate
the role and biochemical effects of fat accumulation in the liver due
to alcohol consumption, dietary fatty acids or obesity, excluding other
factors that could influence hepatocyte behavior. A useful model is
the human hepatocyte-derived cell line HepG2. Palmitic (C16:0)
and oleic (C18:1) acids are the most abundant FFA in liver triglyc-
erides in both normal subjects and patients with NAFLD
(Gómez-Lechón et al., 2007). Gómez-Lechón et al. (2007) have dem-
onstrated that the FFA mixture containing the proportion of oleic
acid/palmitic acid (oleate/palmitate, 2:1 ratio, 1 mM) is associ-
ated with minor toxic and apoptotic effects, thus representing a
cellular model of steatosis in which unsaturated FFAs serve a pro-
tective function against lipotoxicity mimicking benign chronic
steatosis. Moreover, similar intracellular levels of lipid over-
accumulation, as in hepatocytes from human steatotic liver, have
been achieved (Gómez-Lechón et al., 2007). We have previously
shown that the recombinant HepG2 cells VL-17A, which express
Cyp2E1 and alcohol dehydrogenase, presented a decreased cell vi-
ability and oxidative damage when they were treated with 100mM
ethanol (EtOH) for 48 h in comparison with untreated VL-17A cells
or HepG2 cells that lack Cyp2E1 activity. VL-17A oxidative damage
induced by EtOH increased peroxide formation and lipid
peroxidation. Also, the ratio GSH/GSSGwas decreased (Valdes-Arzate
et al., 2009).
The aim in this work was to evaluate if there is an increasing
damage susceptibility of steatotic VL-17A cells by EtOH biotrans-
formation. The wide prevalence of obesity and alcohol use in society
makes this an important liver health problem. This in vitro model
would allow to evaluate the damage induced by FFA, EtOH bio-
transformation, and the susceptibility that FFA confers to hepatocytes
to the EtOH aggression independently.
2. Materials and methods
2.1. Cell culture
The recombinant HepG2 cells (VL-17A), which express Cyp2E1 and alcohol de-
hydrogenase, were routinely grown in monolayer culture in Williams E medium
supplemented with 10% fetal bovine serum (Hyclone Lab Inc., Logan UT, USA), 1%
antibiotics in a humidified atmosphere of 5% CO2/95% air. Mediumwas replaced twice
a week and cells were trypsinized and diluted every 7 days at a ratio of 1:3. All ex-
periments were carried out using 225,000 cells/cm2. In order to lessen ethanol
evaporation all dishes were wrapped with parafilm during time of treatment.
2.2. Experimental design
Twenty-four hours after cells platting, the culture media were replaced with a
serum freemedium and after 4 h themedia were replaced with a serum freemedium
containing 1 mM of a mix of free fatty acids, such as oleic and palmitic (2:1). After
24 h, cells were treated with 100 mM EtOH final concentration for 48 h. Free fatty
acids were present during EtOH treatment. Controls with only free fatty acids or EtOH
were seeded and treated at the same time. All chemicals were purchased from Sigma
Aldrich Chemical (St Louis MO, USA).
2.3. Oil red O staining
To detect intracellular neutral lipids accumulation, cells were seeded onto 24-well
chambers. After treatments, cells werewashedwith ice-cold phosphate-buffered saline
(PBS) and then fixed with 2.5% paraformaldehyde for one hour, then cells were stained
with freshly diluted 0.2% Oil red O solution for 4 h. Oil red was then removed, and cells
were washed 4 times with tap water. After washing and drying completely, 0.2ml of
isopropanol was the added to each well and incubated for 10min, followed by gently
vibration to release oil redO from steatosis staining. ODmeasurementwas done atwave-
length 510. Parallel experimentswere performed counterstainingwith crystal violet for
microphotography.
2.4. Triglycerides determination
Triglycerides (TG) content was determined using the triglyceride determina-
tion kit (Sigma-Aldrich, St Louis MO, USA) following manufacturer’s instructions.
2.5. Trypan blue exclusion test
Cells were seeded and, after treatments, viability was determined by measur-
ing the ability of living cells to exclude trypan blue dye at 0.2% final concentration.
Living cells were counted in a ViCell, Cell Viability Analyzer (Beckman Coulter, Brea
CA, USA).
2.6. LDH activity
Medium from cells of the different treatments was decanted and centrifuged
at 3000 rpm for 10 min and the supernatant was stored at −70 °C until the time of
assay. Cytotoxicity was evaluated by measuring extracellular lactate dehydroge-
nase (LDH) activity. The assay was carried out as previously described (Moldeus et al.,
1978).
2.7. Apoptosis and necrosis determination by flow cytometry
Apoptotic and necrotic cell death were determined using an Annexin V Fluos
staining kit (Roche Applied Science, Pleasanton CA, USA) according to manufactu-
rer’s instructions. Samples were analyzed with FACSCalibur flow cytometer (Becton
Dickinson, Franklin Lakes NJ, USA). Apoptotic cells were identified as Annexin V
positive/PI negative cells in quadrant 3 (Q3).
2.8. Cell extracts preparation and immunoblotting
Protein content was determined by Western blotting as previously reported
(Gomez-Quiroz et al., 2005). Briefly, 1.5 × 106 cells which were seeded and differ-
ent treatments done. Cells were washed twice with ice-cold PBS. The cell pellet was
resuspended in 200 μl of M-Per (Pierce Chemical, Rockford IL, USA); M-Per lysis buffer
(Pierce Chemical, Rockford IL, USA) was supplemented with proteases and phos-
phatases inhibitors (Roche Applied Science, Peniberg, Germany). Lysis was performed
on ice for 15 min, and cell debris was removed by centrifugation at 10,000 g at 4 °C
for 10 min, supernatant was recovered and proteins were separated by electropho-
resis using 4–20% Mini-Protean TGX precast gels (Bio-Rad, Hercules CA, USA) and
transferred to a polyvinylidene difluoride (PVDF) membranes (Invitrogen, Carlsbad
CA, USA). Immunodetection was performed using the indicated primary antibod-
ies: anti-Cyp2E1 (Cell Signaling, Danvers MA, USA, concentration 1:1000), anti
superoxide dismutase (SOD) 1 (concentration 1:2000), antiSOD2, (concentration
1:3000), anti-glutathione peroxidase (GSHPx, concentration 1:1000) 1/2, anti-
actin (concentration 1:10,000), and gamma-glutamylcysteine synthetase(γ-GCS,
concentration 1:1000) (Santa Cruz Biotechnology, Dallas TX, USA), anti-catalase,
(Sigma-Aldrich, St Louis, MO, USA concentration 1:3000), followed by horseradish
peroxidase-conjugated secondary antibody (Amersham, Pistacaway NJ, USA, con-
centration 1:8000) and detection by an incubation with SuperSignal West Pico
Chemiluminescent Substrate (Pierce Chemical, Rockford, IL, USA).
2.9. Reactive oxygen species (ROS) detection
Intracellular ROS was monitored by 6-carboxy-2′,7′-dichlorodihydrofluorescein
diacetate (DCFH-DA), as previously reported (Clavijo-Cornejo et al., 2013). Briefly,
cells (2 × 105 cells) were washed with ice-cold PBS and incubated with DCFH-DA
for 30 min. Cells were scraped and suspended in ice-cold PBS in the dark and flu-
orescence intensity wasmeasuredwith excitationwavelength of 503 nm and emission
wavelength of 529 nm using a Multimode Detector (DTX880, Beckman Coulter). A
positive control with cells treated with 250μM H2O2 for 3 h was used.
2.10. Protein oxidation
Oxidative modification of proteins generates protein carbonyl groups, which rep-
resent a hallmark of oxidation status of all proteins. Carbonyl groups were
immunodetected using an Oxyblot kit (Millipore, Dormstadt, Germany) according
to the manufacturer’s instructions.
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2.11. Total protein determination
Protein concentrationwas determined using a bicinchoninic acid kit (Pierce Chem-
ical, Rockford IL, USA), according to the manufacturer’s instructions.
2.12. Statistical analysis
The data are presented as mean ± SEM for at least three independent experi-
ments. Comparison between groups were performed by one-way analysis of variance
(ANOVA) with Bonferroni post hoc test using GraphPad Prism 5 for Mac OSX. Dif-
ferences were considered significant at *p ≤ 0.05.
3. Results
3.1. FFA treatment results in intracellular lipid accumulation
In order to confirm the FFA uptake by VA-17A cells, oil red stain-
ing was performed in all treatments. Microscopic images showed
the presence of cytoplasmic lipid droplets in FFA and FFA plus EtOH
treated cells (Fig. 1b and c). This pattern was evident with that seen
in non-FFA treated cells. Quantitative approach was taken by the
extraction and spectrophotometric measurement of oil red. Fig. 1e
clearly shows that FFA treated cells increased 4.6-fold the lipid ac-
cumulation, in comparison with NT cells. VL-17A cells exposure to
one mM oleic and palmitic acid (2:1) for 72 h plus EtOH induced
7.7-fold lipid accumulation compared with control cells.
3.2. FFA overload enhances EtOH metabolism-induced cell damage
VL17A cells with FFA significantly decreased the viability deter-
mined by trypan blue exclusion (Fig. 2a). Moreover, this effect is more
evident in cells treated with FFA plus EtOH, suggesting that lipid
overload enhanced cell damage induced by EtOHmetabolism, which
in addition decreases by itself, cellular viability. To explore further,
LDH activity was measured in culture media. Fig. 2b shows that, al-
though FFA increased LDH leakage, EtOH treatment exacerbated this
effect. To address cell apoptosis and necrosis we performed the FACS
analysis of Annexin V and propidium iodide (PI). VL17A cells treated
with both FFA and EtOH presented 17% cells in apoptosis and 25%
in necrosis, while FFA treatment produced 11% apoptosis and 9%
necrosis, and EtOH-treated cells presented 10% apoptosis and 6%
necrosis (Fig. 2c); this result confirms that FFA enhanced the tox-
icity induced by EtOH metabolism.
3.3. FFA and EtOH increase CYP2E1 protein content and
oxidative damage
In order to explain the increment on EtOH metabolism-induced
toxicity we looked at the expression of Cyp2E1 (Fig. 3). EtOH treat-
ment significantly increases Cyp2E1 content (1.6-fold). A similar effect
was observed with FFA alone treatment (2.3-fold); however, the FFA
pretreatment significantly increased Cyp2E1 content (3.2-fold).
Due to our group’s previous report that VL-17A cells treated with
EtOH exhibited oxidative damage, judged by lipid and protein ox-
idation (Valdes-Arzate et al., 2009), we decided to quantify ROS
production by using 2′-7′-dichlorodihydrofluorescein diacetate
(DCFH), a cell-permeable non-fluorescent probe that is de-esterified
intracellularly and converted to the highly fluorescent 2′-7′-
dichlorofluorescein upon oxidation by ROS (Clavijo-Cornejo et al.,
2013). As Fig. 4a shows FFA pretreatment induced the increment
in ROS production due to EtOHmetabolism. Interestingly, FFA alone
treatment also increased ROS values. To confirm these observa-
tions we decided to determine protein oxidation (Fig. 4b); result
shows that treatment with only FFA or only EtOH increased the
content of protein carbonyl groups in VL17A cells, and the effect was
increased in FFA and EtOH treatment cells, which indicates an oxi-
dative damage process.
3.4. FFA and EtOH upregulate the antioxidant defense in VL-17A cells
Then, we decided to explore the status of the main antioxidant
enzymes. As Fig. 5 depicts, SOD1, SOD2 and GSHPx were evalu-
ated by Western blot. Interestingly, SOD1 and 2 exhibited an
increment with FFA alone, but just SOD1 was enhanced in the other
treatment, suggesting a clear compromise in mitochondria when
the two insults are present. GSHPx was increased only in FFA + EtOH,
proposing a compensatory response initiated by SOD1 increment
in the management of reactive oxygen species.
γ-GCS and catalase exhibited no effect by any treatment (Fig. 5).
Fig. 1. Free fatty acids treatment induces lipid overload in VL-17A cells. Cells were treated with free fatty acids (FFA) 1 mM and/or ethanol (EtOH, 100 mM) as indicated in
Materials and Methods. (a–d) Oil red O staining for detection of neutral lipids. Images are representative of at least three independent experiments. Original magnification
200×. (e) Quantification of triglycerides content. Each column represents mean ± SEM of three independent experiments. Differences were considered significant at * p ≤ 0.05
vs NT cells, and # p ≤ 0.05 vs FFA treated cells.
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4. Discussion
Steatosis is one of the most common liver diseases in Western
countries. Important pathophysiological changes, an increased
susceptibility of steatotic liver to injury have been reported. (Rolo
et al., 2012).
The wide prevalence of alcohol abuse in society makes it an im-
portant cofactor in many other liver diseases. In this way, it is
Fig. 2. Free fatty acids induce cell damage and decrease in viability. Cell viability determined by (a) trypan blue exclusion test and (b) by lactate dehydrogenase activity.
Each column represents mean ± SEM of three independent experiments. Differences were considered significant at * p ≤ 0.05 vs NT cells and # p ≤ 0.05 vs FFA treated cells.
Differences were considered significant at * p ≤ 0.05 vs NT cells and # p ≤ 0.05 vs FFA treated cells. (c) Cell death assayed by flow cytometry using Annexin-V- FLUOS stain-
ing kit following manufacturer’s instructions. Quadrant (Q) 1, necrotic; Q3, apoptotic; and Q4 normal cells. 10,000 cells were acquired by event.
Fig. 3. Cyp2E1 is overexpressed by free fatty acids. Whole cell lysate was obtained and subjected to Western blotting. (a) Representative image of the immunoblot. (b) den-
sitometric analysis of protein content relative to actin used as loading control. Each column represents mean ± SEM of three independent experiments. Differences were
considered significant at * p ≤ 0.05 vs NT cells, and # p ≤ 0.05 vs FFA treated cells.
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Fig. 4. Lipid overload enhances ROS production and oxidative damage induced by ethanol metabolism. (a) Reactive oxygen species determination by DCFH. Each column
represents mean ± SEM of three independent experiments. Differences were considered significant at * p ≤ 0.05 vs NT cells and # p ≤ 0.05 vs FFA treated cells. (b) Protein
oxidation determined by Oxyblot kit as referred under Materials and Methods. Image is representative of at least 4 independent experiments.
Fig. 5. Antioxidant enzymes expression as a consequence of free fatty acids and ethanol treatment. (a) Representative image of the immunoblot of at least three indepen-
dent experiments. (b) Densitometric analysis of protein content relative to actin used as loading control. Each column represents mean ± SEM of three independent experiments.
Differences were considered significant at * p ≤ 0.05 vs NT cells, and # p ≤ 0.05 vs FFA treated cells.
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important to address the effect of EtOH on steatotic hepatocytes.
FFA overload in VL-17A cells may serve as a good in vitro model
for studying fatty liver disease. Consistent with previous reports,
we revealed that 1 mM oleic and palmitic acids (2:1) could induce
steatosis that can be assessed by oil red O staining (Fig. 1). Our results
show that FFA treatment increased triglyceride content in all ex-
perimental treatments, with a 7.7-fold increment in FFA plus EtOH
treated cells. As VL-17A cells accumulate intracellular lipids there
is a significant decrease in cell viability in approximately 50% while
LDH activity increased 3.8-fold in cells after the second insult, sug-
gesting that cells are particularly dying by necrosis. VL-17A cells
treated with FFA and then EtOH presented 17% cells in apoptosis
and 25% in necrosis while FFA treatment produced 11%
apoptosis and 9% necrosis, and EtOH treated cells presented 10%
apoptosis and 6% necrosis. Percentage of cell death did not
present an additive effect when cells were exposed to the two
insults, although under this condition, cells presented the highest
death.
Free fatty acids not oxidized by mitochondria mainly do by Cyp
2E1 (Lu et al., 2008). Cyp2E1 induction potentiated liver injury in
obese mice, and the elevated oxidative stress could be blunted by
Cyp2E1 inhibitors (Dey and Cederbaum, 2007). S-adenosyl-L-
methionine decreased oxidative stress, steatosis, liver injury, and
mitochondrial dysfunction in obese mice. In ethanol fed rats plus
high fat diet, serumprotein adducts withMDA and 4-hydroxynonenal
were significantly increased, accompanied by an increase in Cyp2E1
(French et al., 1993). Thus, Cyp2E1 contributes considerably to the
oxidative stress in hepatocytes. Steatotic VL-17A cells treated with
EtOH increased 3.5-fold Cyp2E1 content, while treatment with only
one of the insults, FFA or EtOH increased 2.1- and 2.3-fold respec-
tively compared with non-treated cells. The Cyp2E1 increment
corresponds to an increase in oxidative stress. Steatotic VL-17A cells
treated with EtOH increased 3.7-fold peroxide production and 3-
and 1.9-fold FFA and EtOH treated cells vs not treated cell value re-
spectively. Protein oxidation, determined by protein carbonyl groups,
showed clearly that cells treated with FFA and EtOH presented more
oxidized proteins than cells treated only with one of the toxics. These
data show that Cyp2E1 increment corresponds to higher oxida-
tive stress damage; thus, cells treated with FFA plus EtOH presented
the highest oxidative stress damage. To deal with oxidative stress,
hepatocytes have available a wide range of antioxidants and sur-
vival factors which are induced by changes in the redox status as
an adaptation response.
GSH is the main protector against oxidative stress in the liver
as we have previously reported (Enriquez-Cortina et al., 2013;
Gomez-Quiroz et al., 2005; Valdes-Arzate et al., 2009) and its rel-
evance in steatosis (Chen et al., 2013; Han et al., 2006) and other
liver pathologies has been well documented. GSH is synthesized in
the cytosol as a response of many signals, including oxidative stress,
and γ-GCS is the rate-limiting enzyme of GSH synthesis. In agree-
ment with our previous report where we showed that one of the
main mechanisms of hepatoprotection induced by the hepatocyte
growth factor (HGF), in VL-17A cells under EtOH treatments, is the
induction of GSH synthesis by a mechanism dependent of γ-GCS ex-
pression and NF-kB activation (Valdes-Arzate et al., 2009), in the
present work we could not see any change in γ-GCS. These results
support the idea that under EtOH toxicity the main antioxidant
system is abrogated, possibly by a mechanism of ROS generation
inmitochondria that consumes GSH available; evenmore, it has been
reported that HepG2 cells conditioned with a mixture of FFA de-
creased intracellular GSH and increased lipid peroxidation (Soardo
et al., 2011), indicating that GSH could be the main target of ethanol
and FFA toxicity. Our data clearly show that, because GSH systems
are diminished, cells could thwart the Cyp2E1-derived ROS by GSH
recyclingmainly driven by GSHPx; as our current data suggest (Fig. 5),
this is related to an increment in SOD1 expression.
Hepatocytes are the main cell types that EtOH, and it is herein
where more antioxidant protection is needed in addition to GSH
system. Our data revealed that some antioxidant proteins are induced
in response to the cell insult. Steatotic hepatocytes treated with
ethanol increased protein expression of the main antioxidant pro-
teins, such as SOD1 and GSHPx, but failed in SOD2, catalase and
γ-GCS.
HepG2 cells devoid of ADH and Cyp2E1 expression did not show
significant decrease in viability, and increase in oxidative stress and
apoptosis when treated with alcohol. However, VL-17A cells exposed
to alcohol were characterized by significant decrease in viability and
increase in oxidative stress. The increased oxidative stress and tox-
icity in VL-17A cells subjected to ethanol exposurewere accompanied
by increases in Cyp2E1 protein expression. Based on this evi-
dence, we consider that steatosis renders hepatocytes susceptible
to damage to another aggression, which increases the production
of ROS in the steatotic hepatocyte resulting in a progression in cel-
lular damage.
Our findings indicate that one of the major mechanisms of EtOH-
induced hepatocellular damage is the breakdown of GSH system,
as we previously reported, by a failure of the activation of NF-kB,
and the presence of a steatotic environment worsened the oxida-
tive effects induced by ethanol metabolism. Inducers of the
reestablishment of GSH could be useful alternatives for the ame-
lioration of liver damage in the alcoholic liver disease and NASH.
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